About PainTEQ

Where innovation
treats the source.

PainTEQ builds purpose-built technology for undertreated pain — starting with the sacroiliac joint, one of the most overlooked sources of lower back pain.

Our story
Scroll
Our story

Built around a joint that’s been overlooked.

PainTEQ was founded in 2013 in Tampa, Florida by people who saw the same gap their colleagues saw: the SI joint patient had injections, or major fusion, and nothing useful in between.

More than a decade later, PainTEQ remains a dedicated builder of solutions for the sacroiliac joint — with a growing body of peer-reviewed clinical evidence and an ongoing commitment to the data that drives better patient outcomes.

16,000+
patients served since first implant
375
patients in published outcomes
17+
peer-reviewed publications
20+
issued and pending patents
Milestones
2013
PainTEQ founded
2017
First SI procedure
2019
First LINQ®® case
2023
Single-use system launch
2024
SECURE 12-month outcomes published
First in-office procedure
CPT 27278 established
2025
15,000+ patients served
2026
JanFirst TRAQ™ case
MayLINQT RCT — IRB Approved
JunTRAQTION Study — first patient
Mission & values · 03

A world where every patient with SI joint dysfunction has access to the fixation solution that fits them — without compromise.

To equip physicians treating SI joint dysfunction with a comprehensive range of evidence-based fixation solutions — from biologically compatible bone allografts to titanium implants — so that every patient, regardless of anatomy, has a clear path to recovery.

F.I.G.H.T

How we show up.

F

Focus.

Disciplined attention on SI joint dysfunction and the patients who need us — we don’t dilute our energy or our mission.

I

Intensity.

We bring urgency and energy to every problem, because patients living with SI joint pain can’t afford to wait.

G

Grit.

We push through setbacks, pivots, and the long paths to approval because the work — and the patients depending on it — matters.

H

Honesty.

We tell the truth to each other, to our customers, and to the data. No spin, no shortcuts, no hiding from hard answers.

T

Team-First.

We win together. Individual achievement means nothing without the collective — we support, challenge, and elevate each other.

Leadership · 04

The team behind the work.

Shanth Thiyagalingam, Chief Executive Officer
Chief Executive Officer

Shanth Thiyagalingam

A medical-science graduate of the University of Sydney with a Masters in Marketing and an MBA from MGSM, Shanth has bridged pharmaceutical and medical-device marketing and strategy across St. Jude Medical and Stryker. He leads PainTEQ with a focus on delivering best-in-class products that help more patients get the right treatment.

View profile
Sharan Kalra, Senior Vice President of Finance
Senior Vice President, Finance

Sharan Kalra

Sharan returned to PainTEQ as SVP Finance in 2026 after serving as CFO at Chargebacks911, and previously led the company’s finance organization as VP, Finance & Accounting. He holds a B.S. in Accounting from the University of South Florida Muma College of Business and began his career at Ernst & Young.

View profile
Lalit Venkatesan PhD, Senior Vice President of Clinical Research
Senior Vice President, Clinical Research

Lalit Venkatesan, PhD

Lalit leads PainTEQ’s clinical evidence program, including the LINQT RCT and TRAQTION study, having joined as SVP of Clinical Research in 2025. He brings more than 15 years of clinical and medical-affairs leadership in neuromodulation and neurodiagnostics at Abbott, Natus Medical, and Saluda Medical, and holds a PhD in Neurosciences and an MS in Computer Engineering from the University of Kansas.

View profile
Dwayne Polzer, Vice President R&D and Quality
Vice President, R&D & Quality

Dwayne Polzer

Dwayne leads PainTEQ’s product development and quality systems, having joined in 2019 as Director of Quality and R&D before being named VP in 2025. He brings deep expertise in device design and controls, FDA quality-system compliance, and risk management, and holds Master’s degrees in Biomedical Engineering and Entrepreneurship from the University of South Florida.

View profile
Tim McMorrow, Vice President of Sales
Vice President, Sales

Tim McMorrow

Tim leads PainTEQ’s U.S. commercial organization, having joined in 2021 as Area Vice President before being named VP of Sales in 2022. He brings more than 20 years of medical-device sales and management experience, including neuromodulation leadership roles at Abbott and Medtronic, and holds a B.S. in Marketing from Cal Poly San Luis Obispo.

View profile
Brittney Misewicz, Vice President of Reimbursement and Market Access
Vice President, Reimbursement & Market Access

Brittney Misewicz

Brittney leads coverage, coding, and payer strategy at PainTEQ, having joined in 2021 and risen through reimbursement roles before being named VP in 2025. With over a decade in healthcare reimbursement, she runs the Patient Access Program supporting clinicians through prior authorization and denials. She holds CPB and MARA certifications.

View profile
Loren Buchanan, Vice President of Marketing
Vice President, Marketing

Loren Buchanan

Loren joined PainTEQ as VP Marketing in 2026 after leading global commercial marketing for Saluda Medical’s Evoke System and a fourteen-year career at Boston Scientific — spanning territory sales, the Spectra WaveWriter launch, and regional sales leadership. He holds a B.A. in Economics from the University of Washington.

View profile
Board of directors · 05

Guidance from across the field.

Five directors bringing perspective from medical device, capital markets, and healthcare.

01

Ashley Friedman

Managing Director, Signet Healthcare Partners

View profile
02

David Kereiakes

Managing Partner, Windham Capital Partners

View profile
03

Robert Kline

Independent, Non-executive Board Member

View profile
04

Mike Sherman

President & CEO, MB Innovations Inc.

View profile
05

Shanth Thiyagalingam

Chief Executive Officer, PainTEQ

View profile
In the news · 06

Press & news.

The latest from PainTEQ — clinical publications, study updates, and company announcements.

Jul 2026

PainTEQ Presents New Scientific Evidence Supporting Cortical-Piercing Posterior Sacroiliac Joint Procedures at ASPN 2026

Read more
Jun 2026

PainTEQ Announces First Patient Enrolled in the TRAQTION Study

Read more
May 2026

PainTEQ Launches TRAQ™, A Next-Generation Posterior Approach to SI Joint Fusion

Read more
Mar 2026

PainTEQ Wins Top VC/PE Honors in Tampa Bay

Read more
Jan 2026

PainTEQ Fuels Next Phase of Growth at NANS 2026 with Strategic Expansion of Innovation, Clinical Initiatives, and Product Portfolio

Read more
Jan 2026

PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research

Read more
Read all news
Careers · 07

Build the SI joint category.

We’re hiring across sales, clinical, marketing, and operations. If you want to help shape an emerging clinical category — not work on an established one — come talk to us.

Get in touch
01
Pioneering category
Posterior, drill-less SI joint fusion didn’t exist a few years ago. You’ll help shape how it grows.
02
Real outcomes
The work shows up in patients’ lives within weeks of the procedure. Few jobs in medical devices give you that feedback loop.
03
Lean and serious
Small enough that the work you do matters tomorrow. Serious enough that the clinical evidence program is real.